Pseudo-mutant P53 is a unique phenotype of <i>DNMT3A</i>-mutated pre-leukemia.

导出 OA

翻译打印收藏纠错

第一作者： Amos,Tuval

第一单位： Department of Immunology, Weizmann Institute of Science, Rehovot, Israel; Department of Hematology, Meir Medical Center, Kfar Saba.

作者： Amos,Tuval ^[1] ; Yardena,Brilon ^[2] ; Hadas,Azogy ^[3] ; Yoni,Moskovitz ^[2] ; Dena,Leshkowitz ^[4] ; Tomer M,Salame ^[4] ; Mark D,Minden ^[5] ; Perry,Tal ^[6] ; Varda,Rotter ^[6] ; Moshe,Oren ^[6] ; Nathali,Kaushansky ^[2] ; Liran I,Shlush ^[7]

作者单位： Department of Immunology, Weizmann Institute of Science, Rehovot, Israel; Department of Hematology, Meir Medical Center, Kfar Saba. ^[1] Department of Immunology, Weizmann Institute of Science, Rehovot. ^[2] Department of Immunology, Weizmann Institute of Science, Rehovot, Israel; Department of Pathology, Sackler Faculty of Medicine, Aviv University, Aviv. ^[3] Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot. ^[4] Princess Margaret Cancer Centre, University Health Network (UHN), Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Medical Oncology and Hematology, University Health Network, Toronto, Ontario, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Ontario. ^[5] Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot. ^[6] Department of Immunology, Weizmann Institute of Science, Rehovot, Israel; Division of Hematology, Rambam Health Care Campus, Haifa, Israel; Molecular Hematology Clinic, Maccabi Healthcare Services, Aviv. liran.shlush@weizmann.ac.il. ^[7]